Application of Telemedicine in the Healthcare Sector

 

Telemedicine is a potential tool that significantly improves patient engagement and makes healthcare more affordable and accessible. Telemedicine first appeared in the late 1950s, and as tele-communication technology has advanced over the years, it has undergone constant change. Telemedicine has a wide range of uses.

It can be difficult and expensive to constantly visit hospitals for minor needs. This becomes challenging for these people to travel so far to see the doctors if they live a long way from the hospital. Additionally, people are forced to follow social distancing and have less interaction with one another in the COVID-19 pandemic era. Breaking these rules puts you at risk and makes the coronavirus more likely to spread. Patients at Corona are continuously under the care of doctors. Their own lives are now in grave danger as a result of this. The best method for lowering the likelihood of viruses spreading to one another has been telemedicine.

According to a report by BIS Research, the global telemedicine market is anticipated to grow to a value of about $123 billion by the end of the next year, 2030.

HOW DOES TELEMEDICINE WORK?

The term "telemedicine" is derived from Latin and Greek. The words "Tele" and "Mederi," which together denote distance and healing, respectively, are of Greek and Latin origin. It was an experiment that many people considered. The ongoing COVID-19 pandemic is one of the main factors that led to this experiment becoming a reality today. Doctors can communicate with patients and interact with them less physically by using telemedicine. In this, medical professionals transmit the necessary data in real time from their computer screen to the patient's computer screen. The patients' lives have been made easier by this technology. They are no longer required to wait in the lengthy lines for their appointments as of right now. Instead, they can use telemedicine applications to connect to any of the doctors from the comfort of their own home. The most winners are those who reside in rural areas. They no longer need to leave their neighborhood to access top-notch medical care.

The deadly coronavirus is currently under attack worldwide. The global healthcare sector now has a valuable and highly effective asset in telemedicine. Instead of travelling to hospitals for treatment, people who have contracted the virus can use this technology to connect with a doctor. Because telemedicine offers such simple connectivity, the telemedicine market has begun to expand quickly in every nation. The  telemedicine market in India was estimated at Rs. 380.22 crores (roughly $5 billion) in 2019 and is projected to reach Rs. 1765.56 crores (roughly $23 billion) by the end of 2025, according to BIS research.

BENEFITS OF TELEMEDICINE TECHNOLOGY:

People can now benefit from telemedicine integration thanks to the constantly developing medical industry, which has made it possible. There is always the option to connect to a doctor via telemedicine to obtain the necessary information and treatments, so one does not need to visit the doctor frequently.

Advantages:

• Precise control over the coronavirus outbreak has been made possible thanks in large part to telemedicine. Because of this technology, patients are less physically attracted to the infection. Until there is an emergency scenario, people are no longer making frequent trips to the hospital.

• Better disease and scenario assessments are made possible by telemedicine. For instance, if one has developed an allergy, the doctor can look about one's home to acquire a better understanding of the condition.

• Enhancing family ties can be accomplished with the aid of telemedicine. The members of many families reside far apart. Therefore, by using this online platform, doctors can also communicate with other users who want to learn more about the patient's illness and take the necessary action.
• In comparison to going to the doctor's office, scheduling an appointment or interacting with a doctor is inexpensive. Saving money with telemedicine may be the best option.

• Telemedicine makes it possible for patients to see their doctor whenever they desire. Sudden discomfort and fever are common in newborn newborns. In such cases, one can call the doctor at midnight and request the necessary details as well as a prescription.

CONCLUSION:

The COVID-19 caused a sudden increase in demand for telemedicine technology. No one wants to go to the hospitals these days unless there is an emergency, so nobody goes there often. The best method of communicating with doctors and obtaining information without leaving your home is now possible thanks to telemedicine. By reducing the need for physical contact, it has decreased the likelihood that people will contract the virus.

Causes and Risks of Lung Cancer in the World

The disease claims millions of lives each year. The WHO report states that cancer will be responsible for almost 10 million deaths in 2020. Lung cancer is the most prevalent cancer among the different types, with 2.21 million cases expected in 2020.

The number of cancer cases and related mortality rates are predicted to increase further in the coming years as a result of significant factors like rising air pollution and risky smoking habits among people. In the United States, 224,000 new cases of lung cancer are anticipated to be diagnosed by the year 2030. According to cancer.net, in 2022, there are expected to be 130,180 lung and bronchus cancer deaths in the
United States and approximately 236,740 new cases of the disease.

The mortality rate and alarmingly high prevalence have placed an unprecedented strain on the healthcare system. Researchers and healthcare professionals are working to develop effective cancer diagnostic and treatment procedures by making the best use of the cutting-edge technology that is currently available.

One such approach that has recently attracted the attention of experts is lung cancer genomic testing. In order to pinpoint the precise type of mutation that differs depending on each person's genetic makeup, a molecular analysis of the tumour is performed. This procedure aids the medical professionals in selecting the most suitable course of action for a specific patient.

Despite the fact that the global market for lung cancer genomic testing is still in its infancy, numerous businesses are making significant investments in R&D to advance the field.

The transition of healthcare systems toward precision diagnostic and precision medicine is responsible for the increase in the adoption of lung cancer genomic testing. The use of cutting-edge technology facilitates making well-informed decisions and leads to better cancer treatment outcomes. Significant opportunities exist in the global lung cancer genomic testing market as a result of rising recommendations from international oncology societies for the use of genomic testing for lung cancer diagnosis.

According to a BIS Research report, the lung cancer genomic testing medicine market was estimated to be worth $1.26 billion in 2020 and is projected to reach $3.27 billion by 2031, growing at a CAGR of 8.97% over the forecast period of 2021–2031.

Causes and Risks of Lung cancer

It is critical to comprehend the disease's underlying causes, risks, and solutions in order to increase public awareness and educate people about its dangers. The same will be covered in more detail in this article. Some possible cancer causes include the ones listed below:

Risk factors leading to lung cancer

1. Smoking- Smoking is the most hazardous habit acquired by humans. It is considered to be the number one cause of lung cancer as 90% of lung cancer cases are attributed to the extreme smoking habits in the patients. Tobacco smoke contains many dangerous chemicals that are known to cause lung cancer.
The chemicals released from cigarette smoke do harm not only the smokers but also the people around them inhaling the smoke through the air. Breathing second-hand smoke puts people at risk for lung cancer or other respiratory illnesses.

2. Exposure to some hazardous chemicals, including asbestos, uranium, arsenic, cadmium, chromium, nickel, and petroleum, increases the risk of lung cancer. The risk of cancer is higher for those who live close to the industries that emit these chemicals.
3. Particle Pollution: The air is filled with a mixture of minuscule solid and liquid particles that are extremely hazardous to human health due to a variety of air pollution causes, including factories, vehicles, mining operations, etc. There is evidence that the risk of lung cancer is increased by air pollution particles.

4. Genes: One's likelihood of developing lung cancer is significantly influenced by genetic factors. A person's risk of developing lung cancer may increase if there is a family history of the disease. It is crucial to seek medical advice and exercise caution if someone in the family currently has lung cancer or has ever had the disease.

To get a free sample of the report, click here - https://bisresearch.com/requestsample?id=1301&type=download

One such difficult and dangerous disease for which people have spent centuries trying to find a cure is cancer. But thanks to technological advancements, the healthcare sector has made remarkable strides in slowing the spread of the disease and enabling accurate early diagnosis. One such instance of a sophisticated diagnostic tool that has helped many 

Interested to know more about the growing technologies in your industry vertical? Get the latest market studies and insights from BIS Research. Connect with us at  https://bisresearch.com/contact-us 

Personalized Neovaccine to Lead the Product Segment for the Global Neoantigen Cancer Vaccine Market

 The BIS Research report on the global neoantigen cancer vaccine market briefly segments the neovaccine market on the basis of product type, type of neovaccine, therapeutic specialty, line of therapy, and region.

 With respect to the overall market share, the personalized neovaccine segment is expected to hold the largest share of 83.49% of the market in 2031, and this trend is expected to continue during the forecast period 2024- 2031.

 The large share can be attributed to the existence of 90.00% personalized neovaccines in the mid stage of clinical development and are expected to reach the market during the forecast period 2024-2031.

For more information on this report visit - Neoantigen Cancer Vaccine Market - Industry Analysis, Trends & Forecast 2031 | BIS Research 

Pipeline Segmentation

•    The emerging neoantigen cancer vaccines are segmented based on product type into personalized and off-the-shelf neovaccines.
•    The emerging neoantigen cancer vaccines are segmented based on disease/application into lung cancer, urinary system cancer, melanoma, liver cancer, head and neck cancer, and blood and bone marrow cancer.
•    The
emerging neoantigen cancer vaccines are segmented based on type of neovaccine into nucleic acid vaccine, peptide vaccine, and dendritic cell vaccine. 
•    The emerging neoantigen cancer vaccines are segmented based on line of therapy into first, second, and later lines therapy. 
•    The emerging neoantigen cancer vaccines are segmented based on development phase into Phase I, II, and III. 
•    The emerging neoantigen cancer vaccines are segmented on the basis of route-of-administration into intradermal, subcutaneous, and intramuscular administrations.

Key Questions Answered in this Report:

•    What are the major market drivers, challenges, and opportunities in the global neoantigen cancer vaccines market?
•    What are the underlying structures resulting in emerging trends within the global neoantigen cancer vaccines market?
•    What key development strategies are implemented by the major players in order to sustain in the competitive market?
•    What are the key regulatory implications in developed and developing regions for neoantigen cancer vaccines?
•    How each segment of the market is expected to grow during the forecast period 2024-2031, and what is the estimated revenue to be generated by each of the segments on the basis of:
        o    Product Type (Personalized and Off-the-Shelf), 
        o    Type of Neovaccine (Nucleic Acid Vaccine, Peptide Vaccine, and Dendritic Cell-Based Vaccine)
        o    Line of Therapy (First Line, Second Line, and Later Lines)
    o       Region, including North America, Europe, Asia-Pacific and Middle East
•    Who are the leading players with significant offerings to the global neoantigen cancer vaccines market? What is the expected market dominance for each of these leading players?
•    Which companies are anticipated to be highly disruptive in the future and why?
•    What are the current treatment gaps, and how neovaccines are expected to fill these gaps?
•    What are the unmet needs in the global neoantigen cancer vaccine market?

Translational Research to Continue as the Leading Application for Cancer Microbiome Sequencing

 With the increasing focus on early-stage cancer screening, research communities and the companies involved in the field of microbiome sequencing are significantly investing in expanding their respective product and service mix. 

As of 2020, the global cancer microbiome sequencing market, by application, was dominated by translational research, holding a 76.78% market share. During the forecast period of 2021-2031, while the change may be positive for the diagnostics application and negative for the translational research, the overall market share will still be dominated by the later with the segment anticipated to hold a 74.18% share in 2031.

 This continuous popularity in demand is majorly due to the increase in developmental research for commercializing products in the market, growing focus on establishing precision medicine in the field of clinical oncology, and increasing fund infusions by the governments worldwide, among others. 

For more information on this report (along with the option to request a sample) visit- https://bisresearch.com/industry-report/cancer-microbiome-sequencing-market.html 

Key Questions Answered in this Report:

•    How is cancer microbiome sequencing revolutionizing the field of oncology?
•    What are the major market drivers, challenges, and opportunities in the global cancer microbiome sequencing market?
•    What are the underlying structures resulting in the emerging trends within the global cancer microbiome sequencing market?
•    How did the COVID-19 pandemic impact the global cancer microbiome sequencing ecosystem?
•    What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
•    What are the key regulatory implications in developed and developing regions pertaining to the use of cancer microbiome sequencing?
•    What are the potential entry barriers, which are expected to be faced by the companies willing to enter a particular region? 
•    How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
        o    Offering (product and service)
        o    Application (translational research and diagnostics)
        o    Technology (next-generation sequencing and polymerase chain reaction)
        o    End User (academic and research institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and other end users)
        o    Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
•    What are the growth opportunities for the cancer microbiome sequencing companies in the region of their operation?
•    Who are the leading players with significant offerings in the global cancer microbiome sequencing market? 
•    Which companies are anticipated to be highly disruptive in the future, and why?

Single Cell Sequencing Techniques and the Impact they have on Medicine and Healthcare

 One such technique for gene sequencing is single cell sequencing, which falls under the category of next-generation sequencing methods. Single cell sequencing looks at the sequence data from individual cells, allowing for a better understanding of cellular differences and the function of a single cell in relation to its microenvironment.

Bioanalytical technology advancements have made it easier to study the dynamic activities of single cells, transcripts, and proteins. It enhances the capacity to research cellular diversity and how it affects both healthy and unwell processes. Bioinformatics is the study and analysis of such vast and intricate biological data, such as genetic codes.

The single cell bioinformatics market is expected to expand significantly thanks to the platforms and technology currently available. The global single cell bioinformatics software and services market was estimated to be worth $205.2 million in 2020, and it is anticipated to grow with a CAGR of 10.89% and reach $634.8 million by 2031, according to a BIS Research market report.

Single Cell Sequencing Techniques' Contribution to Medical Research

Single cell sequencing methods (SCS) are regarded as a potent tool for characterising complex populations and studying rare cells. SCS techniques for DNA and RNA analysis have significantly influenced a wide range of biological disciplines over the past few years, including microbiology, neurobiology, development, tissue mosaicism, immunology, and cancer research. The following section discusses a few of these contributions to SCS technology.

• SSC technology makes it possible to analyse and comprehend various cell types, leading to a better understanding of the genetic variations of cancer. On the basis of DNA/RNA variations, it aids in characterising specific tumours and providing detailed information on the clonal evolution. It may involve researching drug-resistant clones, metastatic clones, cancer stem cells, and lineage analysis.

Additionally, it is employed to learn more in-depth information about intricate neural tissues. Additionally, single-cell sequencing makes it simple to identify cell types and markers. Understanding personal variations in biological processes and developmental biology is aided by this.

• Rare cell type identification and analysis: SSC technology has proven to be very effective in locating and analysing rare cell types. The NGS approach and microarrays are the most frequently used methods for this purpose, but they have some drawbacks.

Single-cell RNA sequencing (scRNASeq) can precisely characterise the hidden population and measure each gene's expression in the case of rare cell types. This aids in getting around the other techniques' cell sample size restriction. A DNA RNA shield can also be used to effectively preserve the samples and improve the results. scRNASeq is the best option for all samples, whether they are plentiful samples of various cell types or rare samples.

• Finding cancer stem cells Everyone is affected differently by a complex disease like cancer in terms of severity, symptoms, and recovery. A significant contributor to tumour growth, drug resistance, and metastasis are cancer stem cells. Analysis of cancer stem cells is crucial early on to ensure accurate cancer diagnosis and treatment based on individual characteristics. In this instance, the SSC analysis is successful.

It aids in the recognition of genetic information, the regulation of genes, and the differentiation of gene expressions in different cells. As a result, it makes it possible for specialists to comprehend intra-tumoral diversity, examine cancer stem cells, and map tumour clones. It offers significant data for cancer research.

Examining developmental trajectories and gene regulatory networks This technology aids in the study of the molecular dynamics of various cell types as they go through various stages of development.

The experts are then able to map the developmental trajectories and comprehend changes in cell fate as a result. Even the transcriptional status of the various individual muscle stem cells and the primary myoblasts can be determined using this technique.

Single-cell sequencing is additionally used to determine the various cellular states and the rate of the cell cycle.

Researchers in science, academia, and the medical field are all beginning to understand the significance of single-cell sequencing techniques. Because of this technology, it is now possible to examine samples at the single-cell level, providing access to in-depth knowledge about disease subtypes and more effective treatments.

SCS has become a significant technology that has significantly advanced healthcare and medicine thanks to its many advantages.

                                           To get a free sample of the report, click here.  

A Key Tool in Medical Procedure: 4K High-Resolution Imaging Technique

 An essential component of the healthcare sector is imaging methods and equipment. The imaging techniques have advanced significantly since X-rays were first used for diagnosis in 1890. Today, a variety of cutting-edge medical procedures like computed tomography (CT) scans, MRIs, ultrasounds, and nuclear medicine imaging, including positron emission tomography (PET), are frequently used.

These cutting-edge imaging techniques give medical professionals a clear view inside the body and provide detailed information about the body's functions and malfunctions. It has many benefits, including early problem detection, precise diagnosis, ongoing monitoring, and improved medical condition management.

In the healthcare industry, 4K technologies are becoming more and more popular. Since its introduction and subsequent technological advancements, 4K medical imaging has found its best use in operating rooms (OR).

With the advent of 4k resolution technology, the healthcare sector will soon be able to advance imaging methods. With a horizontal resolution of 4000 pixels, or four times that of high definition, 4K technologies are generally referred to as imaging and visualisation technologies (HD).

High-quality imaging techniques are becoming increasingly important as demand for minimally invasive surgery (MIS) increases globally. Patients can clearly benefit from MIS surgery in a number of ways, including reduced blood loss, smaller incisions, shorter hospital stays, and improved procedure accuracy. However, because they rely so heavily on laparoscopic cameras, surgeons currently have restricted vision.

The global 4K medical imaging market is predicted to grow significantly over the coming years as a result of the rising demand for superior visualisation quality in the medical industry and the availability of technologically cutting-edge products for high-definition medical imaging.

According to the BIS Research market report, the global 4K medical imaging market was valued at $822.1 million in 2019 and is anticipated to reach $2.39 billion by 2030, growing at a CAGR of 12.2% during the forecast period 2020-2030.

The benefits of 4K imaging

Less Pixelated Images- Due to the large monitors used in operating rooms, pixelated images are frequently a problem that makes it difficult to distinguish minute details when necessary.

For instance, surgeons will be able to see the pixels in a 31-inch full HD monitor even when viewing it from one metre away. However, pixels cannot be seen in a 4K monitor of the same size when viewed at the same distance. As a result, every last detail will be obvious.

The large pixel sizes of today's HD monitors can be distracting and result in blurry images when viewed up close.

In delicate procedures like operating on tiny blood vessels with tiny sutures, this can be a risky scenario in the operating room. With the aid of 4K monitors, surgeons can see inside patients clearly, resulting in a more effective procedure.

Increased Visibility and Depth Perception- Minimally invasive surgery is currently the preferred technique in many cases because it causes less pain for patients than traditional open surgery. High-resolution imaging technique is one of the advanced technologies that must be incorporated into minimally invasive surgery procedures.

Because clear visibility of the inner organs is critical to the procedure's success, equipment with increased depth perception and picture clarity, including resolution, brightness, and colour, is required.

Clear visibility can be achieved with a 4K monitor and a 4K camera by improving image clarity with the higher pixel density that 4K provides. This increase in clarity has the potential to improve depth perception. By being able to see how light reacts to objects more clearly, surgeons will be able to better sense depth.

Effective Even with Full HD Input- A 4K camera input is recommended to get the most out of a 4K monitor and ensure that images are as crisp and detailed as possible.

However, some models include the smart resolution with sparse coding (SRSC) function, which improves the clarity of expanded images. This works perfectly when displaying full HD images on 4K monitors, allowing the user to fully utilise the 4K monitor without requiring 4K camera input.

Conclusion

Although existing full HD resolution techniques are proving to be extremely useful in their various applications, 4k technology has the potential to improve efficiency even further. Governments and private healthcare stakeholders are making significant investments.

To get a free sample of the report, click here.  

Gene Cloning is a Molecular Genetics Technique for Creating DNA Copies

 

Gene cloning is an essential component of precision medicine because it ensures that targeted therapies are both safe and effective. It also makes data collection easier for a wide range of therapy dissemination, emphasizing its importance in healthcare.

Gene cloning is a common method or technique used in molecular genetics to duplicate DNA, and its services also aid in drug treatment efficacy monitoring.

The gene cloning service has transformed the distribution of treatments for common diseases. Rapid service development and simultaneous adoption by major corporations have elevated the global gene cloning services market to one of the most profitable markets.

So, what do Gene Cloning Services provide?

A few examples of gene cloning services are:

Gene Expression is the process by which all living cells, including prokaryotes and eukaryotes, function.

Several methods exist for studying and quantifying gene expression and regulation. Some of these approaches are centuries old and well-established, while others, such as multiplex techniques, are relatively new.

Genome Organization: The term "genome organisation" refers to the sequence of the genome rather than its structure. The DNA of an organism is made up of an array of four nucleotides arranged in a specific pattern that provides inherent information. Every creature's genome contains multiple DNA molecules.

Transgenic organisms: These have had their genomes modified. The vast majority of transgenic organisms are created in labs for research.

It is a genetically altered creature whose genetic makeup has been altered using genetic modification techniques, the insertion of altered genes, or the introduction of genes from other organisms. It is the method used the most frequently to acquire genetically modified (GMO) foods.

Gene therapy is a type of treatment that, in addition to treating a hereditary condition, entails inserting one or more genes created in a lab into the genetic material of a patient's cells. To treat and prevent disease, it makes use of genes.

Production of Recombinant Proteins: The biological sciences, biotechnology, and medicine all heavily rely on the production of recombinant proteins. Either cell-based technologies or cell-free technologies can be used to accomplish it. The oldest method of producing a lot of protein is through cell-based systems.

Instead, host cells are chosen based on the gene involved. Different host cells, such as those derived from bacteria, yeast, baculovirus/insect, and mammalian cells, can produce proteins.

According to BIS Research, the global gene cloning services market was valued at $1.98 billion in 2020 and is expected to grow at a CAGR of 17.29% from 2021 to 2031.

Technological Development in Cloning Services

A rise in molecular cloning, molecular diagnostics research, and disease profiling is being driven by improvements in gene cloning services. Additionally, it is anticipated that ongoing technological developments in the services will accelerate market growth.

Research on vector cloning or plasmid at various levels is being done by numerous research institutions, pharmaceutical companies, and laboratories to treat various diseases.

Cloning and subcloning have long been used by molecular and cellular scientists as standard tools.

A crucial step in creating a reliable mammalian cell culture manufacturing platform is efficient clone selection.

These developments offer exceptional opportunities that advance the field of gene cloning services and fuel further expansion of the world market for these services.

The biological validity of the cloned product is now a crucial consideration in the development of cloning techniques. Advances in cancer, cell, and molecular biology in particular have transformed gene therapy.

In short, the goal of gene cloning services is to duplicate DNA. Additionally, it provides prognostic evaluations for a variety of diseases and aid in selecting treatments and keeping track of drug treatment effectiveness.